drugset / Trial / NCT03648333
Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects (N=27)
RandomizedParallel-groupOpen-labelBasic science
Summary
To assess the pharmacokinetic characteristics of valsartan and S-amlodipine after single oral administration of Exforge tab. 10/160mg, a combination formulation of valsartan and amlodipine as reference drug and Lodivixx tab. 5/160mg, a combination formulation of valsartan and S-amlodipine as test drug in healthy male adults
Timeline
- Start
- 2013-12
- Primary completion
- 2014-02
- Completion
- 2014-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Amlodipine | Other / unclassified | 10 mg | Oral |
| Subject | S-amlodipine | Unknown | 5 mg | Oral |
| Comparator | Valsartan | Small molecule | 160 mg | Oral |
Indications
No indication recorded.